A Randomized, Open-label, Multicenter, Parallel-group, Exploratory Study to Evaluate the Efficacy of Intravenous Brivaracetam and Intravenous Phenytoin in Subjects Experiencing Nonconvulsive Electrographic Seizures

Trial Profile

A Randomized, Open-label, Multicenter, Parallel-group, Exploratory Study to Evaluate the Efficacy of Intravenous Brivaracetam and Intravenous Phenytoin in Subjects Experiencing Nonconvulsive Electrographic Seizures

Discontinued
Phase of Trial: Phase II

Latest Information Update: 15 Apr 2016

At a glance

  • Drugs Brivaracetam (Primary) ; Phenytoin
  • Indications Seizures
  • Focus Therapeutic Use
  • Sponsors UCB
  • Most Recent Events

    • 14 Dec 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 14 Jul 2014 Planned End Date changed from 1 Feb 2016 to 1 Mar 2017 as reported by ClinicalTrials.gov record.
    • 05 Jun 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top